Regulations

FDA Issues Warning Letter to Cosmetic Manufacturers Pty Ltd. in Australia

The note summarizes violations of CGMP regulations.

The United States Food and Drug Administration (FDA) issues a warning letter to Cosmetic Manufacturers Pty Ltd. of Queensland, Australia for violations of Current Good Manufacturing Practice (CGMP) regulations for finished pharmaceuticals. The FDA inspected the drug manufacturing facility from March 31 to April 8, 2025. In a letter dated Fab. 6, 2026, it said: “The United States Food and Drug Administration (FDA) inspected your drug manufacturing facility, Cosmetic Manufacturers (Aust) Pty...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters